Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNEUMOSTEM Phase II for Severe BPD in Premature Infants
NCT03392467Phase 2Completed
- Sponsor
- MEDIPOST
- Start
- Aug 2018
- Primary completion
- Jan 2024
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of pneumostem in bronchopulmonary dysplasia (BPD), sponsored by MEDIPOST. Started Aug 2018; status: completed.
02
Drugs
pneumostem
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03392467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392467.